Archived Facts

LYON (Reuters) – Sanofi’s Genzyme unit has received positive feedback from U.S. doctors after the recent launch of multiple sclerosis pill Aubagio and moving toward refiling its FDA application for MS drug Lemtrada, senior executives said on Friday.

Popular Posts:

Related Posts:

Leave a Reply